Other Viruses Citation List:
November 11 - November 24, 2011
Hepatitis B Virus
1. Synthesis, Stability and Pharmacological Evaluation of a Novel Codrug Consisting of Lamivudine and Ursolic acid. Zhong, Y., Z. Dai, Y. Xu, Y. Teng, and B. Wu, European journal of pharmaceutical sciences : Official Journal of the European Federation for Pharmaceutical Sciences, 2011. [Epub ahead of print]; PMID[22085635].
[PubMed]. OV_1111-112411.
Hepatitis C Virus
2. The Design, Synthesis and Biological Evaluations of C-6 or C-7 Substituted 2-Hydroxyisoquinoline-1,3-diones as Inhibitors of Hepatitis C Virus. Chen, Y.L., J. Tang, M.J. Kesler, Y.Y. Sham, R. Vince, R.J. Geraghty, and Z. Wang, Bioorganic & Medicinal Chemistry, 2011. [Epub ahead of print]; PMID[22100256].
[PubMed]. OV_1111-112411.
3. Potent and Selective Inhibition of Hepatitis C Virus Replication by Novel Phenanthridinone Derivatives. Salim, M.T., H. Aoyama, K. Sugita, K. Watashi, T. Wakita, T. Hamasaki, M. Okamoto, Y. Urata, Y. Hashimoto, and M. Baba, Biochemical and Biophysical Research Communications, 2011. [Epub ahead of print]; PMID[22085716].
[PubMed]. OV_1111-112411.
4. PD 404,182 is a Virucidal Small Molecule that Disrupts Hepatitis C Virus and Human Immunodeficiency Virus. Chamoun, A.M., K. Chockalingam, M. Bobardt, R. Simeon, J. Chang, P. Gallay, and Z. Chen. Antimicrobial Agents and Chemotherapy, 2011. [Epub ahead of print]; PMID[22083468].
[PubMed]. OV_1111-112411.
5. Inhibition of Hepatitis C Virus Replication by Monascus Pigment Derivatives that Interfere with Viral RNA Polymerase Activity and the Mevalonate Biosynthesis Pathway. Sun, J.M., S.J. Kim, G.W. Kim, J.K. Rhee, N.D. Kim, H. Jung, J. Jeun, S.H. Lee, S.H. Han, C.S. Shin, and J.W. Oh, The Journal of Antimicrobial Chemotherapy, 2011. [Epub ahead of print]; PMID[22076990].
[PubMed]. OV_1111-112411.
6. Multiple Effects of Honokiol on the Life Cycle of Hepatitis C Virus. Lan, K.H., Y.W. Wang, W.P. Lee, K.L. Lan, S.H. Tseng, L.R. Hung, S.H. Yen, H.C. Lin, and S.D. Lee, Liver International: Official Journal of the International Association for the Study of the Liver, 2011. [Epub ahead of print]; PMID[22098176].
[PubMed]. OV_1111-112411.
Human Cytomegalovirus
7. In Vitro Evaluation of the Activities of the Novel anti-Cytomegalovirus Compound AIC246 (letermovir) against Herpesviruses and Other Human Pathogenic Viruses. Marschall, M., T. Stamminger, A. Urban, S. Wildum, H. Ruebsamen-Schaeff, H. Zimmermann, and P. Lischka, Antimicrobial Agents and Chemotherapy, 2011. [Epub ahead of print]; PMID[22106211].
[PubMed]. OV_1111-112411.
Herpes Simplex Virus 2
8. Structures and anti-HSV-2 Activities of Neutral Polysaccharides from an Edible Plant, Basella rubra L. Dong, C.X., K. Hayashi, Y. Mizukoshi, J.B. Lee, and T. Hayashi, International Journal of Biological Macromolecules, 2011. [Epub ahead of print]; PMID[22085753].
[PubMed]. OV_1111-112411.
Citations from the ISI Web of Knowledge Listings for O.V.
9. Development of New Sulfur-containing Conjugated Compounds as anti-HCV Agents. Hwu, J.R., S.Y. Lin, S.C. Tsay, R. Singha, B.K. Pal, P. Leyssen, and J. Neyts, Phosphorus Sulfur and Silicon and the Related Elements, 2011. 186(5): p. 1144-1152; ISI[000296318300014].
[WOS]. OV_1111-112411.
10. Discovery of Highly Potent Small Molecule Hepatitis C Virus Entry Inhibitors. Mittapalli, G.K., A. Jackson, F. Zhao, H. Lee, S. Chow, J. McKelvy, F. Wong-Staal, and J.E. Macdonald, Bioorganic & Medicinal Chemistry Letters, 2011. 21(22): p. 6852-6855; ISI[000296423700043].
[WOS]. OV_1111-112411.
11. (-)-Epigallocatechin gallate Inhibits Hepatitis C Virus (HCV) Viral Protein NS5B. Roh, C. and S.K. Jo, Talanta, 2011. 85(5): p. 2639-2642; ISI[000296115600056].
[WOS]. OV_1111-112411.
12. Target Specific Hyaluronic acid-Interferon Alpha Conjugate for the Treatment of Hepatitis C Virus Infection. Yang, J.A., K. Park, H. Jung, H. Kim, S.W. Hong, S.K. Yoon, and S.K. Hahn, Biomaterials, 2011. 32(33): p. 8722-8729; ISI[000295858700040].
[WOS]. OV_1111-112411.
13. Synthesis of Purine Modified 2 '-C-Methyl nucleosides as Potential anti-HCV Agents. Zhang, H.W., L.H. Zhou, S.J. Coats, T.R. McBrayer, P.M. Tharnish, L. Bondada, M. Detorio, S.A. Amichai, M.D. Johns, T. Whitaker, and R.F. Schinazi, Bioorganic & Medicinal Chemistry Letters, 2011. 21(22): p. 6788-6792; ISI[000296423700030].
[WOS]. OV_1111-112411.
14. Complement L-Ficolin Binds to Surface Glycans of HCV and Reduces the Viral Infectivity, and Functions as an Antiviral Opsonin. Zhao, Y.N., Y.D. Zhou, K. Yang, and X.L. Zhang, Glycobiology, 2011. 21(11): p. 1475-1475; ISI[000296045300073].
[WOS]. OV_1111-112411.